G Medical Innovations Holdings Ltd.
(NASDAQ : GMVD)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Electronic Technology » Electronic Equipment Or Instruments
symbolcompany%chnglast%shortavg$volume
FTVFortive Corp. 2.28%61.980.5%$193.96m
KEYSKeysight Technologies, Inc. 2.83%145.260.3%$162.79m
IIVIII-VI, Inc. 6.58%62.082.0%$103.19m
TRMBTrimble, Inc. 3.11%69.232.1%$87.94m
CGNXCognex Corp. 6.80%49.301.8%$69.65m
FCELFuelCell Energy, Inc. 6.03%4.221.2%$67.77m
STSensata Technologies Holding Plc 2.23%47.337.9%$50.21m
MRCYMercury Systems, Inc. 1.65%57.445.5%$26.55m
NOVTNovanta, Inc. 0.51%125.710.7%$17.60m
ITRIItron, Inc. 3.21%52.681.6%$17.28m
PARPAR Technology Corp. 4.99%38.920.2%$12.38m
VUZIVuzix Corp. 10.94%6.295.7%$11.86m
MIRMirion Technologies, Inc. 5.63%8.260.0%$11.53m
COHUCohu, Inc. 3.42%30.541.0%$10.46m
DBDDiebold Nixdorf, Inc. 1.78%3.1511.4%$8.54m

Company Profile

G Medical Innovations Holdings Ltd. engages in the development of mobile and e-health solutions and monitoring service platforms. It operates through the following segments: Products, Patient Services, and Covid-19 Testing. The Products segment includes the development, manufacture, and marketing of trans-telephonic and wireless diagnostic equipment for the medical industry and consumer market. The Petient Services segment comprises cardiac monitoring services of MCT, Patch, Event, Extended Holter, and Pacemaker. The Covid -19 Testing segment covers three kinds of diagnostic tests which are Rapid Antigen + A/B Flu Combo test, PCR test, and Antibody test. The company was founded in August 2014 and is headquartered in George Town, Cayman Islands.